AI assistant
ELUTIA INC. — Director's Dealing 2022
Dec 28, 2022
34697_dirs_2022-12-27_52b50c6f-41e3-4f2b-9184-2d95684c5ee5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AZIYO BIOLOGICS, INC. (AZYO)
CIK: 0001708527
Period of Report: 2022-12-22
Reporting Person: HighCape Capital, L.P. (N/A)
Reporting Person: HIGHCAPE PARTNERS, L.P. (10% Owner)
Reporting Person: HIGHCAPE PARTNERS QP, L.P. (10% Owner)
Reporting Person: HighCape Partners GP, LLC (10% Owner)
Reporting Person: HighCape Partners GP, L.P. (10% Owner)
Reporting Person: HighCape Co-Investment Vehicle I, LLC (10% Owner)
Reporting Person: HighCape Co-Investment Vehicle II, LLC (Director, 10% Owner)
Reporting Person: HighCape Capital, LLC (10% Owner)
Reporting Person: Zuga Matt (Director, 10% Owner)
Reporting Person: RAKIN KEVIN (Director, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-12-22 | Stock Option (Right to Buy) | $3.80 | A | 17533 | Acquired | 2032-12-21 | Class A Common Stock (17533) | Indirect |
Footnotes
F1: This option vests in full and shall be fully exercisable on June 20, 2023, subject to Mr. Rakin's continuing in service on the Issuer's board of directors through the vesting date.
F2: Granted to Kevin L. Rakin as non-employee member of the Issuer's board of directors.